Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
BiomX Inc.
Next earnings ≈ Aug 19, 2026 · est. from filing cadence
High return on equity (2780.3%).
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
BiomX Inc. shows limited reported revenue, and 2780.3% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
Sources: SEC EDGAR (CIK 0001739174, latest 10-Q filed 2026-05-20) · EODHD · rules-based read · as of 6/18/2026, 12:43:17 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$35.5M | -$27.2M | -$25.3M | -$44.5M | -$41.5M |
| Net income | -$36.2M | -$28.3M | -$26.2M | -$17.7M | -$36.2M |
| Diluted EPS | $1.39 | $0.95 | $5.10 | $58.31 | $22.19 |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
501 tracked peers · median
| 2026-03-17 | Yeganeh Reuven Director | Acquired (C) | 530K @ $2.00 | $1.06M |
| 2026-03-17 | Yeganeh Reuven Director | Sell | 530K @ $5.00 | $2.65M |
| 2026-03-16 | Yeganeh Reuven Director | Acquired (C) | 450K @ $2.00 | $900K |
| 2026-03-16 | Yeganeh Reuven Director | Sell | 450K @ $5.00 | $2.25M |
| 2026-03-13 | Yeganeh Reuven Director | Acquired (C) | 370K @ $2.00 | $740K |
| 2026-03-13 | Yeganeh Reuven Director | Sell | 370K @ $5.00 | $1.85M |
| 2026-03-12 | Yeganeh Reuven Director | Sell | 300K @ $5.00 | $1.50M |
| 2026-03-11 | Yeganeh Reuven Director | Acquired (C) | 300K @ $2.00 | $600K |
| 2025-04-14 | Wolfson Marina Chief Financial Officer | Award | 68.5K |